Health Services Research
Latest posts by Health Services Research (see all)
- Understanding the New Current Population Survey Health Insurance Questions - Apr. 20, 2015
- The Role of Outcome Forecasts in Patients’ Treatment Decisions—Evidence from a Survey… - Apr. 17, 2015
- Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More… - Apr. 16, 2015
- Transformative Use of an Improved All-Payer Hospital Discharge Data Infrastructure for… - Apr. 16, 2015
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: